MARYBETH FISHER: Open Payments
NPI 1699459354 · SOUTHINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 16 payments from 8 companies in 2025. Trend: 2023 $70 · 2024 $456 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $128 |
| Lilly USA, LLC | 3 | $55 |
| Exact Sciences Corporation | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Novo Nordisk Inc | 1 | $25 |
| Dexcom, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: QULIPTA, The Cologuard Plus Collection Kit, JARDIANCE, MOUNJARO, UBRELVY, LEQVIO, Dexcom G6 Transmitter, SKYRIZI.
Industry payments across CT — which companies pay providers there.
